🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you attending our ATVB WLC networking event 📅 THIS Sunday ⏰ 6:00–8:30 p.m!? This event is an integral part of the GROWTH (Generating Resources and Opportunities for Women in Technology and Health) initiative led by our committee! Read more: ahajournals.org/doi/full/10.11…

#cnicconference CNIC Chiara Giannarelli Chiara Giannarelli shared her recent results on how SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. nature.com/articles/s4416…

🚨 New discovery alert! 🚨 In this month’s issue of Nature Cardiovascular Research, we identify a dendritic cell population that acts as a hub for immune checkpoint communication within human atherosclerotic plaques. NYU CVRC Chiara Giannarelli rdcu.be/d1S6b

FASCIN1+ DCs in mouse and human plaques are a key target of immunotherapies linked to accelerated atherosclerotic plaque progression and increased risk of stroke and myocardial infarction in cancer survivors. #CardioOncology

So fun to collaborate with GiannarelliLab on this! This discovery opens new possibilities for understanding cardiovascular risks in cancer survivors and the role of immune checkpoints in atherosclerosis 🎯 International Cardio-Oncology Society Javid Moslehi

A study in Nature Cardiovascular Research maps the expression of immune checkpoints in atherosclerosis and examines the influence of lipid-lowering treatments and type 2 diabetes to understand how immune checkpoint inhibitors worsen cardiovascular risk in cancer survivors. go.nature.com/3CUR5Mt

Why might some #cancer drugs increase risk for #heartattack and #stroke? Kudos to Dr Chiara Giannarelli and colleagues on this important work! Click below to learn more. GiannarelliLab Dr. Jeffrey Berger William Blau Dr. James Underberg

Another potential indication for statins in stage I-III lung cancer being treated with radiotherapy - to reduce the risk of durva-related accelerated atherosclerosis! Looking forward to seeing some clinical data next to see if that signal holds... Corinne Faivre-Finn Gerry Hanna

In a new study, researchers NYU Grossman School of Medicine show how abdominal CT scans may be repurposed to look for heart disease. With the help of an AI tool, the team used the scans to accurately predict coronary artery calcification. Learn more: bit.ly/4gnEcsL Miriam Bredella, MD, MBA, FACR RSNA

Excited to share my first Co-author paper with Jose Gabriel Barcia Duran #Immune checkpoint landscape of human atherosclerosis. We mapped the immune checkpoint interactome in the atherosclerotic plaque and identified CCR7+ FSCN1+ DCs as crucial checkpoint-hub in the arterial

Congrats to @hauke_horstmannn, new postdoc in @GiannarelliLab, for his cross-species scRNA-seq study on atherosclerosis featured on the CVR cover! 🎉 Read: academic.oup.com/cardiovascres/… CVR Tomasz Guzik NYU Department of Medicine

Thanks Eric Topol for highlighting our work on #ICIs and #atherosclerosis rdcu.be/d1S6b Nature Cardiovascular Research GiannarelliLab Chiara Giannarelli Kathryn Moore Lab

Great to read the commentary that Jesse Williams Lab Esther Lutgens wrote on our paper on #ICIs and #atherosclerosis rdcu.be/d1S6b Nature Cardiovascular Research GiannarelliLab Kathryn Moore Lab Chiara Giannarelli

Thrilled to see our latest research published in Nature Cardiovascular Research 🎉! Excited to contribute new insights into ICI therapy impact on atherosclerosis. Huge thanks to the amazing team and collaborators for making this possible. GiannarelliLab Dayasagar Das, PhD Chiara Giannarelli

Congratulations Natalia!

Congratulations to Dr. Elena Aikawa! We appreciate all you do to support women in the fields of arteriosclerosis, thrombosis, and vascular biology. Elena Aikawa Brigham and Women’s CICS #VascularDiscovery25